Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Satellite constellations could obscure most space telescope observations by late 2030s: 'That part of the image will be forever lost' - 2Nature's Treats: 10 Organic products That Lift Prosperity
- 3Nurturing Hacks: Shrewdness from Experienced Mothers and Fathers
- 4From Overpowered to Coordinated: Individual Accounts of Cleaning up
- 5The Best Design Bloggers for Style Motivation
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- 6 Eyewear Brands Worth Purchasing
- The most effective method to Guarantee Simple Availability in Seniors' SUVs
- Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- Instructions to Choose the Best Web based Advertising Degree Program for Your Objectives
- These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- 'We need everyone,' wounded reservist urges Knesset panel to advance haredi draft law
